Pancreatic Cancer: Beyond Brca Mutations

Pancreatic Cancer: Beyond Brca Mutations

Pancreatic cancer is the fourth-leading cause of cancer-related deaths worldwide. The outcomes in patients with pancreatic cancer remain unsatisfactory. In the current review, we summarize the genetic and epigenetic architecture of metastatic pancreatic cancer beyond the BRCA mutations, focusing on...

Full description

Bibliographic Details
Main Authors: Vincenzo Ricci, Teresa Fabozzi, Maria Anna Bareschino, Emiddio Barletta, Domenico Germano, Immacolata Paciolla, Vincenza Tinessa, Antonio Maria Grimaldi
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Journal of Personalized Medicine
Subjects:
metastatic pancreatic cancer
target therapy
pathway
PARP inhibitor
BRCA mutation
Online Access:https://www.mdpi.com/2075-4426/12/12/2076

Internet

https://www.mdpi.com/2075-4426/12/12/2076

Similar Items